Can magnetic resonance imaging enhance the assessment of potential new treatments for cognitive impairment in mood disorders
Opportunities for CPG Companies Not only is there an overall pursuit of healthier foods, but the appetite-suppressing effects of GLP-1 drugs are expected to result in a 2.5% decrease in food consumption in the US
DOI: 10.1111/j.1364-3703.2004.00265.x 99
Resistance mechanisms to immune checkpoint inhibitors: updated insights
A person with a BMI of 28 and a history of gestational diabetes may benefit from one of these medications to lose weight while concomitantly mastering lifestyle behaviors, and then transition off the weight management medications to lifestyle alone, says Linda Gigliotti, MS, RDN, CDCES, CSOWM, an obesity and weight management specialist based in Irvine, California
Cespiati, A